← Back to Discover
Birchview Capital, LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $213,828,198
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- KLA CORPORATION · COM NEW · 482480100 · shares: $53,846,485
- BRISTOL-MYERS SQUIBB CO · COM · 110122108 · shares: $17,127,142
- LAM RESEARCH CORPORATION · COM NEW · 512807306 · shares: $15,166,550
- SOLID BIOSCIENCES INC · COM NEW · 83422E204 · shares: $6,655,298
- INTELLIA THERAPEUTICS INC · COM · 45826J105 · shares: $6,520,968
- BIODESIX INC · COM · 09075X108 · shares: $6,467,429
- STOKE THERAPEUTICS INC · COM · 86150R107 · shares: $5,827,759
- OVINTIV INC · COM · 69047Q102 · shares: $5,659,875
- NEKTAR THERAPEUTICS · COM · 640268306 · shares: $5,654,610
- CORCEPT THERAPEUTICS INC · COM · 218352102 · shares: $4,973,540
Reported holdings
73 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| KLA CORPORATION | COM NEW | 482480100 | — | 178,471 shares | $53,846,485 |
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | — | 297,243 shares | $17,127,142 |
| LAM RESEARCH CORPORATION | COM NEW | 512807306 | — | 35,000 shares | $15,166,550 |
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | — | 666,196 shares | $6,655,298 |
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | — | 385,400 shares | $6,520,968 |
| BIODESIX INC | COM | 09075X108 | — | 286,804 shares | $6,467,429 |
| STOKE THERAPEUTICS INC | COM | 86150R107 | — | 178,110 shares | $5,827,759 |
| OVINTIV INC | COM | 69047Q102 | — | 107,500 shares | $5,659,875 |
| NEKTAR THERAPEUTICS | COM | 640268306 | — | 81,000 shares | $5,654,610 |
| CORCEPT THERAPEUTICS INC | COM | 218352102 | — | 57,200 shares | $4,973,540 |
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | — | 27,190 shares | $4,582,467 |
| PROTHENA CORP PLC | SHS | G72800108 | — | 449,019 shares | $4,395,896 |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | — | 171,000 shares | $4,326,300 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 35,018 shares | $4,292,506 |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | — | 1,675,000 shares | $3,668,250 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 408,100 shares | $2,824,052 |
| ALKERMES PLC | SHS | G01767105 | — | 50,000 shares | $2,619,750 |
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | — | 33,251 shares | $2,602,556 |
| CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | — | 69,900 shares | $2,600,979 |
| CYTOKINETICS INC | COM | 23282W605 | — | 30,000 shares | $2,555,700 |
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | — | 199,000 shares | $2,489,490 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 57,758 shares | $2,478,396 |
| UNITED THERAPEUTICS CORP | COM | 91307C102 | — | 4,506 shares | $2,441,486 |
| ZENAS BIOPHARMA INC | COM | 98937L105 | — | 93,601 shares | $2,375,593 |
| UNIQURE NV | SHS | N90064101 | — | 50,697 shares | $2,335,104 |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | COM | 69404D108 | — | 1,350,000 shares | $2,268,000 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 17,000 shares | $2,265,420 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 220,000 shares | $2,241,800 |
| BIOGEN INC | COM | 09062X103 | — | 9,000 shares | $1,944,540 |
| EQT CORPORATION | COM | 26884L109 | — | 34,619 shares | $1,840,692 |
| BIOAGE LABS INC | COM | 09077V100 | — | 69,000 shares | $1,691,190 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | — | 29,000 shares | $1,647,490 |
| QUIDELORTHO CORP | COM | 74838J101 | — | 89,377 shares | $1,565,438 |
| AXSOME THERAPEUTICS INC | COM | 05464T104 | — | 6,000 shares | $1,468,620 |
| FOGHORN THERAPEUTICS INC | COM | 344174107 | — | 281,937 shares | $1,375,853 |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | — | 313,616 shares | $1,329,732 |
| STRUCTURE THERAPEUTICS INC | SPONS ADR | 86366E106 | — | 24,000 shares | $1,288,080 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 21,032 shares | $1,269,492 |
| NOVO NORDISK A/S | ADR | 670100205 | — | 24,000 shares | $1,150,560 |
| FREEPORT-MCMORAN CL-B | CL-B | 35671D857 | — | 18,035 shares | $1,134,198 |
| IMMUNOME INC | COM | 45257U108 | — | 50,000 shares | $1,059,500 |
| PHARVARIS N V | COM | N69605108 | — | 29,847 shares | $1,032,109 |
| HARROW HEALTH INC | COM | 415858109 | — | 24,000 shares | $1,019,280 |
| ADAGENE INC | ADS | 005329107 | — | 240,000 shares | $1,008,000 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 20,000 shares | $940,800 |
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | — | 71,218 shares | $781,974 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 8,741 shares | $651,030 |
| 4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | — | 48,505 shares | $645,117 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 16,487 shares | $606,722 |
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | — | 55,000 shares | $596,750 |
| CAMP4 THERAPEUTICS CORP | COM | 13463J101 | — | 120,000 shares | $524,400 |
| SAVARA INC | COM | 805111101 | — | 80,000 shares | $492,800 |
| CANDEL THERAPEUTICS INC | COM | 137404109 | — | 47,756 shares | $491,887 |
| ALTIMMUNE INC | COM NEW | 02155H200 | — | 152,681 shares | $464,150 |
| COMPASS PATHWAYS LTD | SPONSORED ADS | 20451W101 | — | 30,000 shares | $424,500 |
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | — | 42,952 shares | $419,641 |
| CULLINAN THERAPEUTICS INC | COM | 230031106 | — | 20,000 shares | $364,200 |
| TRINITY CAP INC | COM | 896442308 | — | 20,000 shares | $357,800 |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | — | 14,352 shares | $345,596 |
| CASTLE BIOSCIENCES INC | COM | 14843C105 | — | 12,984 shares | $309,668 |
| INVIVYD INC | COM | 00534A102 | — | 342,275 shares | $298,601 |
| GRACE THERAPEUTICS INC | COM | 00439U104 | — | 120,000 shares | $272,400 |
| KAYNE ANDERSON BDC INC | COM SHS | 48662X105 | — | 20,000 shares | $270,600 |
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | — | 75,147 shares | $263,015 |
| PULMONX CORP | COM | 745848101 | — | 200,543 shares | $260,706 |
| INTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026 | 45826J105 | 45826J105 | — | 500 shares | $260,000 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 20,655 shares | $202,832 |
| KYNTRA BIO INC | COM NEW | 31572Q881 | — | 22,566 shares | $170,373 |
| ELUTIA INC | COM | 05479K106 | — | 165,094 shares | $161,726 |
| QUOIN PHARMACEUTICALS LTD | SPONSORED ADS | 74907L409 | — | 20,000 shares | $96,800 |
| LIPOCINE INC | COM NEW | 53630X203 | — | 16,712 shares | $42,783 |
| DOCGO INC | COM | 256086109 | — | 39,062 shares | $20,160 |
| GOSSAMER BIO INC | COM | 38341P102 | — | 18,176 shares | $2,992 |